Vanta Bioscience Limited (BOM:540729)

Vanta Bioscience Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	1.64	1.61	0.97	2.24	26.5	1.95
Cash & Short-Term Investments	1.64	1.61	0.97	2.24	26.5	1.95
Cash Growth	20.13%	66.20%	-56.90%	-91.54%	1258.41%	-96.26%
Accounts Receivable	24.45	31.41	19.59	11.34	20.15	13.91
Other Receivables	-	-	-	37.21	35.27	19.41
Receivables	77.12	89.15	73.39	48.55	55.42	33.33
Inventory	90.18	75.21	71.58	72.36	97.64	140.07
Prepaid Expenses	-	-	-	1.27	2.35	0.17
Other Current Assets	5.67	5.64	6.5	20.57	17.45	22.94
Total Current Assets	174.62	171.61	152.43	144.98	199.36	198.46
Property, Plant & Equipment	263.08	284.06	332.29	373.15	348.59	228.99
Long-Term Investments	-	9.1	9.1	14.2	-	-
Other Intangible Assets	145.72	125.34	106.04	56.88	-	-
Long-Term Deferred Charges	257.47	257.47	239.95	215.86	138.66	48.62
Other Long-Term Assets	15.56	6.39	7.28	8.96	9.68	9.68
Total Assets	856.45	853.97	847.09	814.04	696.29	485.75
Accounts Payable	52.3	55.69	42.19	24.64	4.65	4.91
Accrued Expenses	-	36.07	26.5	32.89	33.69	25.1
Short-Term Debt	-	2.91	2.91	32.21	41.52	18.84
Current Portion of Long-Term Debt	137.02	120.24	98.04	46.49	39.81	18.34
Current Income Taxes Payable	-	-	-	0.39	0.62	0.81
Other Current Liabilities	45.52	13.87	7.83	6.17	28.14	30.74
Total Current Liabilities	234.84	228.77	177.47	142.79	148.43	98.74
Long-Term Debt	521.18	488.01	470.67	369.97	278.36	136.51
Long-Term Deferred Tax Liabilities	6.99	7.45	9.65	7.84	7.22	5.91
Other Long-Term Liabilities	-	-	-0	-	0	-
Total Liabilities	763.02	724.23	657.79	520.6	434.02	241.16
Common Stock	63.12	63.12	63.12	63.12	63.12	63.12
Additional Paid-In Capital	-	152.12	152.12	152.12	152.12	152.12
Retained Earnings	-	-63.25	-40.09	24.83	23.95	19.45
Total Common Equity	136.3	151.99	175.15	240.07	239.19	234.69
Minority Interest	-42.87	-22.26	14.15	53.37	23.09	9.9
Shareholders' Equity	93.44	129.73	189.3	293.44	262.27	244.59
Total Liabilities & Equity	856.45	853.97	847.09	814.04	696.29	485.75
Total Debt	658.21	611.16	571.61	448.67	359.7	173.69
Net Cash (Debt)	-656.57	-609.55	-570.65	-446.43	-333.2	-171.74
Net Cash Per Share	-104.05	-96.57	-90.41	-70.73	-52.79	-27.21
Filing Date Shares Outstanding	6.31	6.31	6.31	6.06	6.31	6.31
Total Common Shares Outstanding	6.31	6.31	6.31	6.06	6.31	6.31
Working Capital	-60.22	-57.16	-25.04	2.19	50.93	99.73
Book Value Per Share	21.61	24.08	27.75	39.63	37.89	37.18
Tangible Book Value	-9.42	26.65	69.11	183.19	239.19	234.69
Tangible Book Value Per Share	-1.49	4.22	10.95	30.24	37.89	37.18
Land	-	-	-	-	11.75	11.75
Buildings	-	-	-	-	60.02	60.02
Machinery	-	-	-	-	119.13	110.36
Construction In Progress	-	-	-	-	193.4	70.05

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.